Biopharma Daily Stock Updates - 3/3/21

$MNOV (-1.75%) Discontinued Covid-19 vaccine development. source

$BTAI (-10.44%) Update on BXCL501 program for dementia, end of phase 2 meeting with FDA scheduled Q2 2021. source

$OVID (+36.49%) Takeda secures rights from Ovid for Soticlestat. source

$ADMA (-1.05%) Kennesaw plasma collection center received FDA approval to implement a Hepatitis B immunization program source

$BPMC (-6.17%) EMA Validation of Type II Variation Marketing Authorization Application for AYVAKYT® (avapritinib) for the Treatment of Advanced Systemic Mastocytosis source

$ORTX (+1.1%) Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics source

$VIR (-27.64%) Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19 source

$PRVB (-4.63%) Proven Publishes data from Teplizumab study source

$LQDA (-3.43%) Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank. source

$RDUS (+2.73%) $175 Million Financing Transaction source

$KRTX (-2.54%) Pricing of Public Offering of Common Stock source